Lymphoblastic Leukemia
Conditions
Interventions
This is a study to evaluate a new diagnostic device. In the first stage, the patients bone marrow samples will be collected and assessed for the presence of chimeric genes by the conventional PCR meth
Sponsors
Instituto Aggeu Magalhães - Fiocruz de Pernambuco
Instituto de Medicina Integral Prof. Fernando Figueira - IMIP
Universidade Federal de Pernambuco
Eligibility
Age
No minimum to 20 Years
Inclusion criteria
Inclusion criteria: Patients with a maximum age of 20 years; both genders; attended at reference services for the treatment of leukemia in Brazil with a clinical and cytological diagnosis of leucemia; who express the desire to participate in the project and the legal guardians sign the Free and Informed Consent Form and the children between 8 and 18 years old sign the Free and Informed Assent Term, providing clinical information, and allowing the analysis of samples (bone marrow) in the laboratory reference of the study in Recife
Exclusion criteria
Exclusion criteria: Patients with mature B-cell Leukaemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the accuracy and effectiveness of molecular qPCR testing for detecting measurable residual disease by harmonizing test performance parameters performed in different laboratories | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes expected | — |
Countries
Brazil
Contacts
Public ContactNorma Lucena-Silva
Fundação Oswaldo Cruz de Pernambuco
Outcome results
None listed